drugset / Trial / NCT02062645
Study of Efficacy and Safety of CVAA489 in Hypertensive Patients
NaSingle-groupOpen-labelTreatment
Summary
The population that will be included in this study, will be regular Turkish hypertensive patients who are expected to consume sodium in high amounts. It is hypothesized that, in that population, amlodipine/valsartan will be effective at the same rate of blood pressure (BP) control rate as expected from literature.
Timeline
- Start
- 2014-02
- Primary completion
- 2015-09
- Completion
- 2015-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amlodipine | Other / unclassified | 5 mg | — |
| Subject | Amlodipine | Other / unclassified | 10 mg | — |
| Subject | Valsartan | Small molecule | 160 mg | — |